Erschienen in:
21.05.2020 | Pharmacology and Pharmacodynamics of Antifungal Agents (J Amsden,, Section Editor)
Antifungal Penetration and Distribution into Organs and Tissue
verfasst von:
Kayla R. Stover, John D. Cleary
Erschienen in:
Current Fungal Infection Reports
|
Ausgabe 3/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
Properties of penetration of antifungals into the body compartments have been reviewed extensively by Felton et al. in 2014, so the goal of this review was to identify new data, including information on ibrexafungerp and rezafungin, in order to provide an updated pharmacotherapy approach in difficult-to-treat infections.
Recent Findings
Along with early identification and early initiation of treatment, assuring sufficient distribution into the infected site is essential for successful therapy. Although there are a limited number, the penetration and distribution of antifungals into organs and tissue are widely variable between agents and classes, and can be affected by factors such as weight, genetics, comorbidities, and inflammation.
Summary
Clinicians should be aware of the challenges of tissue and organ penetration. Using existing human and animal data can help assure that penetration will be sufficient with the chosen antifungal prior to initiating therapy.